Kyntra Bio (KYNB) Receivables - Net (2014 - 2026)

Kyntra Bio has disclosed Receivables - Net across 13 years of filings, most recently posting $347000.0 for Q2 2026.

• In Q2 2026, Receivables - Net rose 155.15% year-over-year to $347000.0; the TTM figure through Jun 2026 stood at $347000.0 (up 155.15% YoY), while the FY2025 annual figure was $5.5 million, up 1043.45% from the prior year.
• Receivables - Net came in at $347000.0 for Q2 2026 at Kyntra Bio, down from $5.0 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $49.2 million in Q1 2022 to a low of $136000.0 in Q2 2025.
• Average Receivables - Net over 5 years is $15.5 million, with a median of $10.9 million recorded in 2022.
• Year-over-year, Receivables - Net sank 99.6% in 2025 and soared 3328.57% in 2026.
• Over 5 years, Receivables - Net stood at $16.3 million in 2022, then plunged by 68.58% to $5.1 million in 2023, then plunged by 90.61% to $481000.0 in 2024, then slumped by 55.09% to $216000.0 in 2025, then surged by 60.65% to $347000.0 in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $347000.0 in Q2 2026, $5.0 million in Q1 2026, and $216000.0 in Q4 2025.